Abstract
Abstract Ketogenic diets have the potential to lower glucose availability to cancer cells. The effect that the resulting increase in ketone bodies has on cancer cells is not fully understood. Here we explored the effect of beta-hydroxybutyrate (BHB) on glucose deprived MCF-7 and T47D breast cancer cells. Cell proliferation was decreased with lower glucose conditions which could not be rescued by either 10 mM or 25 mM BHB supplementation. Gene expression changes were altered when cells were glucose deprived. Smaller changes were observed when gene expression changes were compared between glucose deprived cells and those treated with BHB. Pathway enrichment analysis demonstrated that glucose deprivation decreased activity of the Hippo-Yap cell signaling pathway in MCF-7 breast cancer cells, while it increased expression of genes of the NRF2-pathawy and genes regulating ferroptosis in T47D breast cancer cells. No significant pathway enrichment was found when glucose deprived cells were treated with BHB. Both cell lines expressed the enzymes (OXCT1/2, BDH1, ACAT1/2) responsible for metabolizing BHB to acetyl-CoA, yet expression of these enzymes does not change with either glucose deprivation or BHB treatment. In the publicly available Cancer Genome Atlas increased expression compared to healthy tissue of enzymes responsible for metabolizing BHB to acetyl-CoA was also observed, however only a small subset of patients showed alterations in these enzymes. This alteration was linked to a significant decrease in overall survival. In conclusion, neither MCF-7 nor T47D breast cancer cells were affected by BHB during glucose deprivation, however screening of the patient’s tumor for activation of ketone bodies metabolizing enzymes may be indicated to identify who will benefit from ketogenic diet interventions. Citation Format: Rylee Maldonado, Chloe Adrienna Talana, Kahealani Uehara, Michael Weichhaus. Breast cancer cell metabolism: Effect of beta-hydroxybutyrate on glucose deprived breast cancer cells [abstract]. In: Abstracts: AACR Special Virtual Conference on Epigenetics and Metabolism; October 15-16, 2020; 2020 Oct 15-16. Philadelphia (PA): AACR; Cancer Res 2020;80(23 Suppl):Abstract nr PO-057.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.